GeneDx Holdings Corp.
WGS· Nasdaq
Quarterly figures for GeneDx Holdings Corp., with source filings when available.
26 quarters. Mar 31, 2020 to Jun 30, 2026. USD.
GeneDx Holdings Corp. has filed its 10-Q within 28 to 34 days of period end across its last 8 quarters. The 10-K runs 51 to 89 days.
GeneDx Holdings Corp. · CIK 1818331 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | Aug 3, 2026 · after-hours | Aug 3, 2026 | 34 d | 10-Q | $114.44M | +11.4% | -$0.60 | |
| Q1 2026 |
|---|
| Mar 31, 2026 |
| May 4, 2026 · after-hours |
| May 4, 2026 |
| 34 d |
| 10-Q |
| $102.25M |
| +17.4% |
| -$2.16 |
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | Feb 23, 2026 · pre-market | Feb 23, 2026 | 54 d | 10-K | $120.99M | +26.5% | — | |
| Q3 2025 | Sep 30, 2025 | Oct 28, 2025 · pre-market | Oct 28, 2025 | 28 d | 10-Q | $116.74M | +51.9% | -$0.27 | |
| Q2 2025 | Jun 30, 2025 | Jul 29, 2025 · pre-market | Jul 29, 2025 | 29 d | 10-Q | $102.69M | +45.6% | $0.36 | |
| Q1 2025 | Mar 31, 2025 | Apr 30, 2025 · pre-market | Apr 30, 2025 | 30 d | 10-Q | $87.12M | +39.6% | -$0.23 | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | Feb 18, 2025 · pre-market | Feb 20, 2025 | 51 d | 10-K | $95.64M | +66.6% | — | |
| Q3 2024 | Sep 30, 2024 | Oct 29, 2024 · pre-market | Oct 29, 2024 | 29 d | 10-Q | $76.87M | +44.2% | -$0.31 | |
| Q2 2024 | Jun 30, 2024 | Jul 30, 2024 · after-hours | Jul 30, 2024 | 30 d | 10-Q | $70.51M | +44.8% | -$1.10 | |
| Q1 2024 | Mar 31, 2024 | Apr 29, 2024 · after-hours | Apr 29, 2024 | 29 d | 10-Q | $62.42M | +44.7% | -$0.78 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | Feb 20, 2024 · after-hours | Feb 23, 2024 | 54 d | 10-K | $57.42M | −6.4% | — | |
| Q3 2023 | Sep 30, 2023 | Oct 30, 2023 · after-hours | Nov 3, 2023 | 34 d | 10-Q | $53.30M | −36.0% | -$1.64 | |
| Q2 2023 | Jun 30, 2023 | Aug 8, 2023 · after-hours | Aug 8, 2023 | 39 d | 10-Q | $48.71M | +34.7% | -$1.84 | |
| Q1 2023 | Mar 31, 2023 | May 9, 2023 · after-hours | May 9, 2023 | 39 d | 10-Q | $43.14M | −20.0% | -$3.04 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Dec 31, 2022 | Mar 14, 2023 · after-hours | Mar 16, 2023 | 75 d | 10-K | $61.35M | +6.1% | — | |
| Q3 2022 | Sep 30, 2022 | Nov 14, 2022 · pre-market | Nov 14, 2022 | 45 d | 10-Q | $83.23M | +92.8% | -$6.72 | |
| Q2 2022 | Jun 30, 2022 | Aug 15, 2022 · after-hours | Aug 15, 2022 | 46 d | 10-Q | $36.17M | −23.1% | -$8.38 | |
| Q1 2022 | Mar 31, 2022 | May 12, 2022 · after-hours | May 12, 2022 | 42 d | 10-Q | $53.94M | −16.0% | -$10.38 | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021 | Dec 31, 2021 | Mar 14, 2022 · after-hours | Mar 14, 2022 | 73 d | 10-K | $57.80M | −9.6% | — | |
| Q3 2021 | Sep 30, 2021 | Nov 15, 2021 · after-hours | Nov 15, 2021 | 46 d | 10-Q | $43.18M | +11.8% | $0.16 | |
| Q2 2021 | Jun 30, 2021 | — | Jul 21, 2021 | 21 d | 10-Q | $47.02M | +56.2% | -$41.94 | |
| Q1 2021 | Mar 31, 2021 | — | May 24, 2021 | 54 d | 10-Q | $64.20M | +37.6% | -$348.82 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020 | Dec 31, 2020 | — | Mar 30, 2021 | 89 d | 10-K | $63.96M | — | — | |
| Q3 2020 | Sep 30, 2020 | — | Nov 16, 2020 | 47 d | 10-Q | $38.61M | — | -$456,573.00 | |
| Q2 2020 | Jun 30, 2020 | — | — | — | — | $30.10M | — | — | |
| Q1 2020 | Mar 31, 2020 | — | — | — | — | $46.66M | — | — | |